Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Gina T, Mootrey"'
Autor:
Michael Martin, Leisa H. Weld, Theodore F. Tsai, Gina T. Mootrey, Robert T. Chen, Manette Niu, Martin S. Cetron
Publikováno v:
Emerging Infectious Diseases, Vol 7, Iss 6, Pp 945-951 (2001)
In 1998, the Centers for Disease Control and Prevention was notified of severe illnesses and one death, temporally associated with yellow fever (YF) vaccination, in two elderly U.S. residents. Because the cases were unusual and adverse events followi
Externí odkaz:
https://doaj.org/article/f050b780173c49c4aabfece93acf17a9
Autor:
Linda J. Neff, Gina T. Mootrey, David L. Swerdlow, Mercedes M. Sniadack, Mary M. McCauley, Richard A. Schieber
Publikováno v:
Clinical Infectious Diseases. 46:S251-S257
Limited information exists regarding intermediate or long-term consequences of cardiac adverse events (CAEs) after smallpox vaccination. We conducted follow up at 5-12 months after vaccination of 203 US civilian vaccinees who reported a possible CAE.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db3de7b3a5c9a2ea53e10ef022ac55b7
https://doi.org/10.1086/524741
https://doi.org/10.1086/524741
Publikováno v:
Clinical Infectious Diseases. 46:S168-S178
Of >39,000 civilian public health responders vaccinated against smallpox in 2003, 203 reported cardiovascular adverse events (CAEs). An association exists between the US vaccinia strain and myocarditis and/or pericarditis ("myo/pericarditis" [MP]). O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6f2d321bfb712ed85345c7b6b514b9a
https://doi.org/10.1086/524380
https://doi.org/10.1086/524380
Publikováno v:
Clinical Infectious Diseases. 46:S153-S156
The following introduction describes the context in which the national smallpox vaccination program was implemented and highlights the significance of the key policy, programmatic, or scientific challenges, observations, and lessons learned that are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9794de66cf57c3f886d8bb3643ab4de
https://doi.org/10.1086/524379
https://doi.org/10.1086/524379
Publikováno v:
Clinical Infectious Diseases. 46:S212-S220
In response to concern about smallpox possibly being used as a biological weapon, the President of the United States launched the National Smallpox Pre-Event Vaccination Program on 13 December 2002. Given safety concerns, identifying potentially seri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68ca96db00d0f08cb111ef2c9730fa86
https://doi.org/10.1086/524742
https://doi.org/10.1086/524742
Publikováno v:
MMWR. Morbidity and mortality weekly report. 64(34)
On March 24, 2015, the Food and Drug Administration licensed an additional combined diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP) and inactivated poliovirus (IPV) vaccine (DTaP-IPV) (Quadracel, Sanofi Pasteur Inc.). Quadracel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95ee04a00e173d1da50cd3eb3781530c
https://pubmed.ncbi.nlm.nih.gov/26334944
https://pubmed.ncbi.nlm.nih.gov/26334944
Autor:
Sarah L. Lathrop, Edward B. Hayes, Sean V. Shadomy, Penina Haber, Susan S. Ellenberg, M. Miles Braun, Gina T. Mootrey, Robert Ball, Robert T. Chen
Publikováno v:
Vaccine. 20:1603-1608
Context: The vaccine adverse event reporting system (VAERS) monitors vaccine safety post-licensure. Although events reported to VAERS are not necessarily causally associated with vaccination, VAERS reports can be used to identify possible safety conc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3aefe6de4a4470fe98e005b9c8100863
https://doi.org/10.1016/s0264-410x(01)00500-x
https://doi.org/10.1016/s0264-410x(01)00500-x
Autor:
Gina T. Mootrey, Elaine Jong, Alejandra Gurtman, Theodore F. Tsai, Michael Martin, Jeff Altman, Manette T. Niu, Martin S. Wolfe, Elizabeth D. Barnett, David O. Freedman, Phyllis E. Kozarsky, Mary E. Wilson, Jan E. Patterson, Michele Barry, Martin S. Cetron, Bradley A. Connor, Leisa H. Weld, Robert T. Chen, Bradley R. Sack, Vernon E. Ansdell, Russell McMullen
Publikováno v:
Emerging Infectious Diseases, Vol 7, Iss 6, Pp 945-951 (2001)
Emerging Infectious Diseases
Emerging Infectious Diseases
In 1998, the Centers for Disease Control and Prevention was notified of severe illnesses and one death, temporally associated with yellow fever (YF) vaccination, in two elderly U.S. residents. Because the cases were unusual and adverse events followi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2695bac8f67f6c0f4e96a15cf9594c1d
https://wwwnc.cdc.gov/eid/article/7/6/01-0605_article
https://wwwnc.cdc.gov/eid/article/7/6/01-0605_article
Publikováno v:
Clinical Infectious Diseases. 32:1273-1280
Recent recommendations by the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices may lead to the increased use of the meningococcal polysaccharide vaccine. The Vaccine Adverse Event Reporting System (VAERS) is u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f8cffb7db998a20eec2a5b4781cbf65
https://doi.org/10.1086/319982
https://doi.org/10.1086/319982
Publikováno v:
Infectious Disease Clinics of North America. 15:21-39
No vaccine is perfectly safe or effective. As diseases such as diphtheria and polio fade, vaccine safety concerns, especially alleged links between vaccinations and several chronic illnesses, have become increasingly prominent in the media and to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::460ed141f4a661fa34527b398346c1c0
https://doi.org/10.1016/s0891-5520(05)70266-x
https://doi.org/10.1016/s0891-5520(05)70266-x